The American Lung Association has initiated a campaign aimed at highlighting the significance of vaccinations to protect against respiratory illnesses this winter. Launched on October 8, 2025, the campaign emphasizes that vaccines are the most effective means to prevent severe illness, hospitalization, and death from respiratory diseases such as influenza, COVID-19, pneumococcal pneumonia, pertussis, and respiratory syncytial virus (RSV).
Every year, millions in the United States suffer from respiratory illnesses, particularly as seasonal virus cases tend to peak between October and March. According to preliminary estimates from the Centers for Disease Control and Prevention (CDC), the 2024-2025 respiratory virus season may see up to 82 million cases of influenza, leading to approximately 37 million medical visits, up to 1.3 million hospitalizations, and between 127,000 and 130,000 deaths. The previous season revealed that COVID-19 vaccinations prevented around 68,000 hospitalizations, 13,000 ICU admissions, and 5,300 in-hospital deaths.
Harold Wimmer, President and CEO of the American Lung Association, stated, “Immunization is especially important for older adults and individuals with certain health conditions who are at increased risk of severe illness.” He further emphasized that not receiving vaccinations increases the risk of severe disease for both individuals and those around them.
Vaccines work by preparing the body to fight off germs like viruses and bacteria. Vaccination typically provides longer-lasting and safer immunity compared to natural immunity gained after an illness. Older adults often have weakened immune systems and may suffer from chronic conditions, making them particularly vulnerable to severe complications from vaccine-preventable respiratory diseases.
The campaign encourages vaccinations against five key respiratory illnesses:
Key Vaccinations for Respiratory Health
1. **Influenza (Flu):** Annual flu vaccination is recommended for everyone aged 6 months and older, ideally in September or October, although vaccinations can continue throughout the flu season.
2. **COVID-19:** The vaccination is advised for everyone aged six months and older, with discussions encouraged between patients and healthcare providers regarding individual circumstances.
3. **RSV:** Adults aged 50-74 at increased risk for severe RSV disease, as well as those aged 75 and older, should receive a single vaccine if they have not been vaccinated previously.
4. **Pertussis (Whooping Cough):** The Tdap vaccine, which protects against pertussis, is recommended for all adults, particularly those with asthma or chronic obstructive pulmonary disease (COPD).
5. **Pneumococcal Pneumonia:** Vaccination is recommended for adults aged 19-49 with specific chronic health conditions and for all adults aged 50 and older.
Pregnant women and individuals with compromised immune systems may have additional vaccination recommendations and should consult with their healthcare provider to ensure they are up to date.
The American Lung Association encourages individuals to discuss their vaccination options with healthcare professionals, as multiple vaccines can often be administered during a single visit. For more information, individuals can contact the Lung Association’s HelpLine at 1-800-LUNGUSA or visit Lung.org/vaccines.
Support for this campaign was provided by Sanofi, a global healthcare leader committed to public health initiatives.
The American Lung Association is dedicated to saving lives by improving lung health and preventing lung diseases. Its strategic goals include defeating lung cancer, championing clean air, enhancing quality of life for those with lung disease, and fostering a tobacco-free future. For more details about the organization, which holds a 4-star rating from Charity Navigator and is a Platinum-Level GuideStar Member, visit Lung.org or call 1-800-LUNGUSA.